BioSpace News Archive

Drug Development

Polarean Imaging Plc - Phase III Clinical Trials update

First patient enrolment at University of Cincinnati

August 5, 2019
·
2 min read
Business

Imcyse announces changes in management and board, appoints Thomas Taapken as executive chairman

Company strengthens board ahead of trial results in type 1 diabetes patients and expansion of indications for its proprietary Imotope™ technology

August 5, 2019
·
4 min read
Vilnius Scientists Develop Cheaper and Faster DNA Testing Method

New ‘Vilnius-Made’ method reduces DNA testing costs by 90%, while the city’s long-standing tradition of life sciences further position Lithuanian Capital as emerging European hub of international scientific development

August 5, 2019
·
3 min read
Deals

CELLINK has entered an agreement to acquire single-cell dispensing company cytena GmbH

CELLINK AB has entered an agreement with the owners of cytena GmbH to acquire all cytena shares for a purchase price of 30.25M euros.

August 5, 2019
·
5 min read
Sanofi exercises Option on Exscientia-designed Bispecific Small Molecule for treatment of immunological conditions

AI Design enables new bispecific small molecule modality

August 5, 2019
·
3 min read
Deals

Cytena GmbH Announces That It Has Been Entered into an Agreement to Be Acquired by CELLINK

The owners of Cytena GmbH have agreed to sell all Cytena shares to CELLINK AB for a purchase price of 30.25M euros.

August 5, 2019
·
4 min read
Deals

GNA Biosolutions Closes $13.5M Series C Financing Round Backed by a US/EU consortium

Funding will finance further development and IVD-CE marking of the company’s first molecular POC (Point of Care) platform, based on Pulse Controlled Amplification (PCA) technology

August 5, 2019
·
2 min read
Business

Oncoceutics and the NCI PPTC Collaborate to Expand ONC201 Development in Pediatric Oncology

Oncoceutics, Inc., announced a collaboration with the National Cancer Institute funded Pediatric Preclinical Testing Consortium to enable tumor type selection for ONC201 clinical trials in pediatric oncology beyond diffuse midline gliomas.

August 5, 2019
·
2 min read